Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...

DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides" report has been added ...

The "Oligonucleotide Synthesis Market: Industry Trends and Global Forecasts, Till 2035 - Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, ...

Oligo Factory’s new low-scale synthesis capability gives researchers the flexibility to order single oligos or small prototype batches, at volumes as low as 50 nmol with the same speed, service, and ...

There’s been this dream for decades. What if we could just print out an entire gene directly, one base at a time? —Daniel Lin-Arlow, Ansa Biotechnologies As scientists set their sights on cell and ...

Oligos are playing a crucial role in driving the progress of modern drug development. Listen to nucleic acid synthesis expert Lina Borozdina deliver a complete class on oligo synthesis starting from ...

During an oral Spotlight Presentation, Codexis unveiled the successful end-to-end enzymatic synthesis of an entire approved siRNA therapeutic asset, inclisiran. Codexis enzymatically synthesized the ...

Oligo Factory, which manufactures oligonucleotides at scale, reports that it is compliant with current Good Manufacturing Practices (GMP). This milestone emphasizes Oligo Factory’s commitment to ...

From synthetic biology and gene therapy to data storage and biofuel production, the demand for synthetic DNA is rising. (1) Chemicals remove the 5’-hydroxyl protecting group. The nucleosides are rich ...

Biogen is also a leading company in the oligonucleotide synthesis market. The recent FDA accelerated approval of QALSODY (Tofersen) for the treatment of amyotrophic lateral sclerosis (ALS) in adults, ...

REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data from ...